Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC
Clinical trial NCT06501664 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06501664
- Sponsor
- Rui-hua Xu, MD, PhD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2026-11-30
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.